Technical Data
C7904-76A
COX 1 (Cyclooxygenase-1, PGHS-1, Prostaglandin Endoperoxide Synthase-1, PHS 1, Ovarian Cancer Marker)
Description:
The prostanoid family includes PGD2, PGE2, PGF2alpha, PGI2, thromboxane A2 and prostaglandins. The prostaglandins (PGs) are implicated in various physiological and pathophysiological events, including male fertility, menstruation, ovulation, pregnancy, implantation and inflamatory and neoplastic diseases. The biosynthesis of PGs and some other prostanoids, is catalyzed in a rate limiting step by PG-H synthase (also known as cyclooxygenase (COX), PG-endoperoxidase synthase (PTGS)) which converts arachiodonic acid to prostaglandin/prostanoid precursor PGH2. Two cyclooxygenase isozymes, COX1 (human, 576aa, 69-72kD; chromosome 9) and COX2 (human, 604aa, 74kD; chromosome 1) have been identified. COX1, a constitutively expressed isoform, produces physiologically relevant prostanoids such as those in stomach and platelets. COX2 isoform is inducible and rapidly upregulated at inflamation sites and forms proinflamatory prostanoids. The overexpression of COX-2 also leads to tumerogenesis. Recently, a third isoform COX3 (canine 633aa; ~65kD in human aorta) has been reported. Two smaller COX1-derived proteins (partial COX1) PCOX1a (canine 414aa, ~53kDa in human aorta) and PCOX1b have also been characterized. The COX3, but not PCOX1a, possesses glycosylation dependent cyclooxygenase activity. The nonsteroidal antiinflammatory drugs (NSAIDs) reduce the formation of prostaglandins by inhibiting the activity of cyclooxygenases (COX1, COX2 and COX3), This ability was associated with inhibition of COX, which converts arachidonic acid to the prostaglandin precursor prostaglandin H2.

Applications:
Suitable for use in Western blotting, Immunohistochemistry, ELISA and ECL.

Recommended dilution:
Western Blotting and Immunohistochemistry: 1:1000 using AP or HRP
Chemiluminescence and ELISA: Further dilution possible.
Optimum dilutions to be determined by researcher.

Storage and Stability:
May be stored at 4C for short-term only. For long-term storage, store at -20C. Aliquots are stable for at least 12 months at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
TypeIsotypeCloneGrade
MabIgG4i175Purified
SizeStorageShippingSourceHost
100ul-20CBlue IceSheepMouse
Concentration:
Immunogen:
Ovine PGHS-1.
Purity:
Form
Supplied as ascetic fluid containing 0.1% sodium azide.
Specificity:
Specifically reacts with sheep PGHS-1 at 1:1000 or higher dilution.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1. DeWitt, D.L., et al., Concentrations of PGH Synthase and PGI2 Synthase in the Endothelium and Smooth Muscle of Bovine Aorta. J. Clin. Invest. 72: 1882 (1983).2. DeWitt, D.L., et al., Orientation of the Active Site and Antigenic Determinants of Prostaglandin Endoperoxide (PGH) Synthase in the Endoplasmic Reticulum. J. Biol. Chem. 256: 10375 (1981).3. Pagels, W.R., et al., Immunochemical Evidence for the Involvement of Prostaglandin Endoperoxide Synthase in Hydroperoxide-Dependent Oxidations by Ram Seminal Vesicles. J. Biol. Chem. 258: 6517 (1983).4. Smith, W.L., and Rollins, T.E., Characteristics of Rabbit Anti-PGH Synthase Antibodies and Use in Immunochemistry. Methods in Enzymology 86: 213 (1982).5. DeWitt, D.L., et al., Monoclonal Antibodies Against PGH Synthase: An Immunoradiometric Assay for Quantitating the Enzyme. Methods in Enzymology 86: 229 (1982).